231 related articles for article (PubMed ID: 31637384)
1. Recent progress in supramolecular peptide assemblies as virus mimics for cancer immunotherapy.
Cai Y; Ran W; Zhai Y; Wang J; Zheng C; Li Y; Zhang P
Biomater Sci; 2020 Feb; 8(4):1045-1057. PubMed ID: 31637384
[TBL] [Abstract][Full Text] [Related]
2. [Cancer immunotherapy].
Kjeldsen JW; Donia M; Svane IM
Ugeskr Laeger; 2018 May; 180(21):. PubMed ID: 29804567
[TBL] [Abstract][Full Text] [Related]
3. From design to clinic: Engineered peptide nanomaterials for cancer immunotherapy.
Du JJ; Su Z; Yu H; Qin S; Wang D
Front Chem; 2022; 10():1107600. PubMed ID: 36733612
[TBL] [Abstract][Full Text] [Related]
4. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
5. Opportunities and challenges in the immunological therapy of pediatric malignancy: a concise snapshot.
Ceppi F; Beck-Popovic M; Bourquin JP; Renella R
Eur J Pediatr; 2017 Sep; 176(9):1163-1172. PubMed ID: 28803259
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer vaccines: Tumor-associated antigens
Wagner S; Mullins CS; Linnebacher M
World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
[TBL] [Abstract][Full Text] [Related]
7. Chiral Nanomaterials for Cancer Vaccines.
Qu A; Sun M; Xu L; Liu L; Guo L; Chen P; Wang Q; Du Z; Wu Z; Xu C; Kuang H
Small Methods; 2024 Mar; 8(3):e2301332. PubMed ID: 37997213
[TBL] [Abstract][Full Text] [Related]
8. Peptide vaccines in cancer-old concept revisited.
Kumai T; Kobayashi H; Harabuchi Y; Celis E
Curr Opin Immunol; 2017 Apr; 45():1-7. PubMed ID: 27940327
[TBL] [Abstract][Full Text] [Related]
9. Peptide-based vaccines for cancer therapy.
Parmiani G; Russo V; Maccalli C; Parolini D; Rizzo N; Maio M
Hum Vaccin Immunother; 2014; 10(11):3175-8. PubMed ID: 25483658
[TBL] [Abstract][Full Text] [Related]
10. Improving the efficacy of peptide vaccines in cancer immunotherapy.
Zahedipour F; Jamialahmadi K; Zamani P; Reza Jaafari M
Int Immunopharmacol; 2023 Oct; 123():110721. PubMed ID: 37543011
[TBL] [Abstract][Full Text] [Related]
11. Molecular Targets in Cancer Therapy - Fourth Biennial Meeting. Mechanism and therapeutic reversal of immune suppression in cancer.
Herber DL
IDrugs; 2007 Apr; 10(4):227-9. PubMed ID: 17390239
[No Abstract] [Full Text] [Related]
12. Peptides as cancer vaccines.
Calvo Tardón M; Allard M; Dutoit V; Dietrich PY; Walker PR
Curr Opin Pharmacol; 2019 Aug; 47():20-26. PubMed ID: 30831470
[TBL] [Abstract][Full Text] [Related]
13. Peptide-Based Treatment: A Promising Cancer Therapy.
Xiao YF; Jie MM; Li BS; Hu CJ; Xie R; Tang B; Yang SM
J Immunol Res; 2015; 2015():761820. PubMed ID: 26568964
[TBL] [Abstract][Full Text] [Related]
14. Peptide-Based Nanomaterials for Tumor Immunotherapy.
Li L; Ma B; Wang W
Molecules; 2020 Dec; 26(1):. PubMed ID: 33396754
[TBL] [Abstract][Full Text] [Related]
15. A Theoretical Basis for the Efficacy of Cancer Immunotherapy and Immunogenic Tumor Dormancy: The Adaptation Model of Immunity.
Manjili MH
Adv Cancer Res; 2018; 137():17-36. PubMed ID: 29405975
[TBL] [Abstract][Full Text] [Related]
16. Are peptide vaccines viable in combination with other cancer immunotherapies?
Ohtake J; Sasada T
Future Oncol; 2017 Aug; 13(18):1577-1580. PubMed ID: 28776424
[No Abstract] [Full Text] [Related]
17. From immune checkpoints to vaccines: The past, present and future of cancer immunotherapy.
Osipov A; Murphy A; Zheng L
Adv Cancer Res; 2019; 143():63-144. PubMed ID: 31202363
[TBL] [Abstract][Full Text] [Related]
18. Combination strategies for enhancing the efficacy of immunotherapy in cancer patients.
Moschella F; Proietti E; Capone I; Belardelli F
Ann N Y Acad Sci; 2010 Apr; 1194():169-78. PubMed ID: 20536466
[TBL] [Abstract][Full Text] [Related]
19. The viral approach to breast cancer immunotherapy.
Arab A; Behravan N; Razazn A; Barati N; Mosaffa F; Nicastro J; Slavcev R; Behravan J
J Cell Physiol; 2019 Feb; 234(2):1257-1267. PubMed ID: 30146692
[TBL] [Abstract][Full Text] [Related]
20. T-cell epitope peptide vaccines.
Elsawa SF; Rodeberg DA; Celis E
Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
